UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

  

FORM 8-K

  

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

 

Date of report (Date of earliest event reported):  March 19, 2018

 

 

Health Discovery Corporation

(Exact name of registrant as specified in charter)

 

 

Georgia 333-62216 74-3002154
(State of incorporation) (Commission File Number)

(IRS Employer

Identification No.)

  

4243 Dunwoody Club Drive, Suite 202, Atlanta GA  30350

(Address of principal executive offices / Zip Code)

  

(678) 336-5300

(Registrant’s telephone number, including area code)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

  ¨ Written communications pursuant to Rule 425 under the Securities Act.
  ¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act.
  ¨ Pre-commencement communications pursuant to Rule 14d—2(b) under the Exchange Act.
  ¨ Pre-commencement communications pursuant to Rule 13e—4(c) under the Exchange Act.

  

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company  ¨

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ¨

 

 

 

 

 

   

ITEM 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

  

On March 19, 2018, Mr. Kevin Kowbel resigned as a Director of Health Discovery Corporation.   A copy of Mr. Kowbel’s resignation notice is attached to this Form 8-K as Exhibit 99.1.

 

 

Item 9.01. Financial Statements and Exhibits.

 

(a) Not applicable
(b) Not applicable
(c) Not applicable
(d) Exhibits.

 

  99.1 Resignation Notice of Mr. Kevin Kowbel

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

 

  HEALTH DISCOVERY CORPORATION
   
   
       
Dated:  March 23, 2018 By: /s/ George H. McGovern, III  
    George H. McGovern, III
    Chairman & Chief Executive Officer

  

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Health Discovery (CE) (USOTC:HDVY)
Gráfico Histórico do Ativo
De Dez 2024 até Jan 2025 Click aqui para mais gráficos Health Discovery (CE).
Health Discovery (CE) (USOTC:HDVY)
Gráfico Histórico do Ativo
De Jan 2024 até Jan 2025 Click aqui para mais gráficos Health Discovery (CE).